Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Decreasing frequency of osteonecrosis of the jaw in cancer and myeloma patients treated with bisphosphonates: the experience of the oncology network of piedmont and aosta valley (north-Western Italy).

Fusco V, Galassi C, Berruti A, Ortega C, Ciuffreda L, Scoletta M, Goia F, Migliario M, Baraldi A, Boccadoro M, Loidoris A, Bertetto O.

ISRN Oncol. 2013;2013:672027. doi: 10.1155/2013/672027. Epub 2013 Feb 27.

2.

Osteonecrosis of the Jaw in Patients With Metastatic Renal Cell Cancer Treated With Bisphosphonates and Targeted Agents: Results of an Italian Multicenter Study and Review of the Literature.

Fusco V, Porta C, Saia G, Paglino C, Bettini G, Scoletta M, Bonacina R, Vescovi P, Merigo E, Lo Re G, Guglielmini P, Di Fede O, Campisi G, Bedogni A.

Clin Genitourin Cancer. 2015 Aug;13(4):287-94. doi: 10.1016/j.clgc.2014.12.002. Epub 2014 Dec 9. Review.

PMID:
25586958
3.
4.

[Bisphosphonates and osteonecrosis of the jaws].

Urade M.

Clin Calcium. 2007 Feb;17(2):241-8. Review. Japanese.

PMID:
17272882
5.

Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.

King AE, Umland EM.

Pharmacotherapy. 2008 May;28(5):667-77. doi: 10.1592/phco.28.5.667. Review.

PMID:
18447663
6.

Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases.

Bagan JV, Murillo J, Jimenez Y, Poveda R, Milian MA, Sanchis JM, Silvestre FJ, Scully C.

J Oral Pathol Med. 2005 Feb;34(2):120-3. Review.

PMID:
15641993
7.

Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.

Van Poznak C, Estilo C.

Oncology (Williston Park). 2006 Aug;20(9):1053-62; discussion 1065-6. Review.

PMID:
16986349
8.

Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?

Van den Wyngaert T, Huizing MT, Vermorken JB.

Ann Oncol. 2006 Aug;17(8):1197-204. Review.

PMID:
16873439
9.

Bisphosphonates and other bone agents for breast cancer.

Wong MH, Stockler MR, Pavlakis N.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD003474. doi: 10.1002/14651858.CD003474.pub3. Review.

PMID:
22336790
10.

[Osteonecrosis of the jaw associated with the use of bisphosphonates in multiple myeloma: report of four cases and literature review].

Li LH, Wu XB, Chen WM, Chen JX, Wu Y, Chen SL.

Zhonghua Yi Xue Za Zhi. 2008 Nov 18;88(42):2986-7. Review. Chinese.

PMID:
19080077
11.

New Non-Bisphosphonate Drugs that Produce Osteonecrosis of the Jaws.

Ramírez L, López-Pintor RM, Casañas E, Arriba Ld, Hernández G.

Oral Health Prev Dent. 2015;13(5):385-93. doi: 10.3290/j.ohpd.a34055. Review.

PMID:
25884045
12.

Bisphosphonate associated osteonecrosis of the jaw.

Khan AA, Sándor GK, Dore E, Morrison AD, Alsahli M, Amin F, Peters E, Hanley DA, Chaudry SR, Lentle B, Dempster DW, Glorieux FH, Neville AJ, Talwar RM, Clokie CM, Mardini MA, Paul T, Khosla S, Josse RG, Sutherland S, Lam DK, Carmichael RP, Blanas N, Kendler D, Petak S, Ste-Marie LG, Brown J, Evans AW, Rios L, Compston JE; Canadian Taskforce on Osteonecrosis of the Jaw.

J Rheumatol. 2009 Mar;36(3):478-90. doi: 10.3899/jrheum.080759. Review.

PMID:
19286860
13.

Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients.

Hoff AO, Toth B, Hu M, Hortobagyi GN, Gagel RF.

Ann N Y Acad Sci. 2011 Feb;1218:47-54. doi: 10.1111/j.1749-6632.2010.05771.x. Epub 2010 Sep 28. Review.

PMID:
20946574
14.

[Osteonecrosis of the jaw and bisphophonates in oncology].

Facon T, Bensadoun RJ, Blanc JL, Confavreux C, Gourmet R, Maes JM, Penel G, Vieillard MH, Woeller A.

Bull Cancer. 2008 Apr;95(4):413-8. doi: 10.1684/bdc.2008.0617. Review. French.

15.

Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.

Rizzoli R, Burlet N, Cahall D, Delmas PD, Eriksen EF, Felsenberg D, Grbic J, Jontell M, Landesberg R, Laslop A, Wollenhaupt M, Papapoulos S, Sezer O, Sprafka M, Reginster JY.

Bone. 2008 May;42(5):841-7. doi: 10.1016/j.bone.2008.01.003. Epub 2008 Jan 18. Review.

PMID:
18314405
16.

Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?

Diel IJ, Fogelman I, Al-Nawas B, Hoffmeister B, Migliorati C, Gligorov J, Väänänen K, Pylkkänen L, Pecherstorfer M, Aapro MS.

Crit Rev Oncol Hematol. 2007 Dec;64(3):198-207. Epub 2007 Sep 12. Review.

PMID:
17855108
17.

Osteonecrosis of the jaw: who gets it, and why?

Reid IR.

Bone. 2009 Jan;44(1):4-10. doi: 10.1016/j.bone.2008.09.012. Epub 2008 Oct 7. Review.

PMID:
18948230

Supplemental Content

Support Center